Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Spyre Therapeutics Inc. shares valued at $522,074 were sold by Burrows Scott L on Sep 03 ’24. At $28.17 per share, Burrows Scott L sold 18,531 shares. The insider’s holdings dropped to 116,422 shares worth approximately $3.91 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As published in their initiating research note from Wedbush on September 04, 2024, Spyre Therapeutics Inc. [SYRE] has been an Outperform and the price target has been revised to $45. Analysts at Evercore ISI started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid July. As of May 02, 2024, Robert W. Baird has initiated its “an Outperform” rating for SYRE. Earlier on March 01, 2024, Wells Fargo upgraded its rating. Their new recommendation was “an Overweight” for SYRE stock which previously was a “an Equal weight”.
Analyzing SYRE Stock Performance
During the last five days, there has been a surge of approximately 3.83%. Over the course of the year, Spyre Therapeutics Inc. shares have jumped approximately 56.18%. Shares of the company reached a 52-week high of $47.97 on 03/18/24 and a 52-week low of $18.54 on 01/03/24. A 50-day SMA is recorded $28.69, while a 200-day SMA reached $30.37. Nevertheless, trading volume fell to 0.59 million shares from 0.39 million shares the previous day.
Support And Resistance Levels for Spyre Therapeutics Inc. (SYRE)
According to the 24-hour chart, there is a support level at 32.32, which, if violated, would cause prices to drop to 31.03. In the upper region, resistance lies at 34.80. The next price resistance is at 35.99. RSI (Relative Strength Index) is 65.97 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.81, which suggests the price will increase in the coming days. Percent R is at 12.95%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
